Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N J Wareham

Showing results (171-180 of 215) with videos related to

Pageof 22
Sort By:
Diabetologia|September 1, 1994
Hypertriglyceridaemia in subjects with normal and abnormal glucose tolerance: relative contributions of insulin secretion, insulin resistance and suppression of plasma non-esterified fatty acidsC D Byrne, N J Wareham, D C Brown, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 1, 1995
Undiagnosed glucose intolerance in the community: the Isle of Ely Diabetes ProjectD R Williams, N J Wareham, D C Brown, et al.
Diabetologia|June 4, 2011
Screening for diabetes using an oral glucose tolerance test within a western multi-ethnic population identifies modifiable cardiovascular risk: the ADDITION-Leicester studyD R Webb, L J Gray, K Khunti, et al.
Trials|February 23, 2010
Rationale and design of the ADDITION-Leicester study, a systematic screening programme and randomised controlled trial of multi-factorial cardiovascular risk intervention in people with type 2 diabetes mellitus detected by screeningD R Webb, K Khunti, B Srinivasan, et al.
Heart (British Cardiac Society)|July 10, 2009
Inflammatory biomarkers and the prediction of coronary events among people at intermediate risk: the EPIC-Norfolk prospective population studyJ S Rana, M Cote, J-P Després, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 19, 2014
Does early intensive multifactorial therapy reduce modelled cardiovascular risk in individuals with screen-detected diabetes? Results from the ADDITION-Europe cluster randomized trialJ A Black, S J Sharp, N J Wareham, et al.
American Journal of Human Biology : the Official Journal of the Human Biology Council|July 28, 2012
Cardiorespiratory fitness and physical activity in Luo, Kamba, and Maasai of rural KenyaD L Christensen, D Faurholt-Jepsen, M K Boit, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 10, 2015
Cost-effectiveness of intensive multifactorial treatment compared with routine care for individuals with screen-detected Type 2 diabetes: analysis of the ADDITION-UK cluster-randomized controlled trialL Tao, E C F Wilson, N J Wareham, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 8, 2016
Habitual chocolate consumption and the risk of incident heart failure among healthy men and womenC S Kwok, Y K Loke, A A Welch, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 25, 2012
Does early intensive multifactorial treatment reduce total cardiovascular burden in individuals with screen-detected diabetes? Findings from the ADDITION-Europe cluster-randomized trialR K Simmons, S J Sharp, A Sandbæk, et al.
Pageof 22

Showing results (171-180 of 215) with videos related to

Sort By:
Pageof 22
Diabetologia|September 1, 1994
Hypertriglyceridaemia in subjects with normal and abnormal glucose tolerance: relative contributions of insulin secretion, insulin resistance and suppression of plasma non-esterified fatty acidsC D Byrne, N J Wareham, D C Brown, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 1, 1995
Undiagnosed glucose intolerance in the community: the Isle of Ely Diabetes ProjectD R Williams, N J Wareham, D C Brown, et al.
Diabetologia|June 4, 2011
Screening for diabetes using an oral glucose tolerance test within a western multi-ethnic population identifies modifiable cardiovascular risk: the ADDITION-Leicester studyD R Webb, L J Gray, K Khunti, et al.
Trials|February 23, 2010
Rationale and design of the ADDITION-Leicester study, a systematic screening programme and randomised controlled trial of multi-factorial cardiovascular risk intervention in people with type 2 diabetes mellitus detected by screeningD R Webb, K Khunti, B Srinivasan, et al.
Heart (British Cardiac Society)|July 10, 2009
Inflammatory biomarkers and the prediction of coronary events among people at intermediate risk: the EPIC-Norfolk prospective population studyJ S Rana, M Cote, J-P Després, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 19, 2014
Does early intensive multifactorial therapy reduce modelled cardiovascular risk in individuals with screen-detected diabetes? Results from the ADDITION-Europe cluster randomized trialJ A Black, S J Sharp, N J Wareham, et al.
American Journal of Human Biology : the Official Journal of the Human Biology Council|July 28, 2012
Cardiorespiratory fitness and physical activity in Luo, Kamba, and Maasai of rural KenyaD L Christensen, D Faurholt-Jepsen, M K Boit, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 10, 2015
Cost-effectiveness of intensive multifactorial treatment compared with routine care for individuals with screen-detected Type 2 diabetes: analysis of the ADDITION-UK cluster-randomized controlled trialL Tao, E C F Wilson, N J Wareham, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 8, 2016
Habitual chocolate consumption and the risk of incident heart failure among healthy men and womenC S Kwok, Y K Loke, A A Welch, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 25, 2012
Does early intensive multifactorial treatment reduce total cardiovascular burden in individuals with screen-detected diabetes? Findings from the ADDITION-Europe cluster-randomized trialR K Simmons, S J Sharp, A Sandbæk, et al.
Pageof 22